Categories Finance
\U0001f4c8| Over 18 million people receive some form of grant payment. Data proves South Africans are increasingly going into poverty due to a failing ANC government and its policies.
— Democratic Alliance (@Our_DA) January 5, 2021
The first sharp increase in these numbers started in the 2004/05 financial year.https://t.co/F06VnnAzbx
1/ Of the 18m grant recipients, around 12m (so 2/3) are children. Caregivers (overwhelmingly women) receive the grant on the child's behalf. The child support grant was only introduced in 1998, so not sure why DA asks for data since 1994. Other grants have not increased hugely.
2/ My uncontroversial opinion: it is good for the state to provide social assistance, as it is constitutionally obliged, to children in poor households. Public opinion data suggests most SAns agree with this sentiment:
3/ Receiving a social grant is associated with numerous developmental improvements for children - e.g. food security; school attendance - and eases some of the financial burden of carers.
4/ The CSG replaced an earlier cash transfer programme, the State Maintenance Grant, because the SMG discriminated against black women. Only citizens of the Republic - not bantustan residents - could receive it. The SMG failed to provide assistance to the poorest rural children.
Coining and Debasement in Henry's Reign https://t.co/bGitKkj7wl via @wordpressdotcom
When Henry VIII and Francis I Spent $19 Million on an 18-Day Party
England's Unwanted Reformation https://t.co/n1a0u1DzNB via @YouTube
Unusual Historicals: Money Matters: The Country Without a Currency https://t.co/gGGHOFG9rk
The Premier Agent business is prob as strong as it has ever been.
Normalized for some accounting nuances, QoQ growth was 20% in Q3 and 27% in Q4.
YoY growth was 13% in 2020 despite a 17% decline in Q2 related to the pandemic.
Reading the tea leaves, it sure sounds like Flex is one of the main drivers of PA revenue acceleration. This is something we talked about in Q3, 2019 when the stock had sold off by 20%+ and was trading in the low 30s
Takeaway No. 2\ufe0f\u20e3:$ZG is expanding its @PremierAgent Flex program.
— KiD \U0001f4b0 (@kidkapital) August 8, 2019
This is crucial so let me explain.
Not gonna claim iBuying is inevitable nor a “good” biz but even skeptics must admit the segment looks more viable today.
And we can all agree iBuying is clearly the superior customer experience compared to the tradition home selling process.
Maybe the most interesting comment made on the call?
The Zestimate will be a live initial offer in some iBuying markets this year 👀
JUST IN: House and Senate Democrats introduce legislation to raise the federal minimum wage from $7.25 to $15 by 2025. pic.twitter.com/yW9hGZmmYK
— NBC Politics (@NBCPolitics) January 26, 2021
One other detail that the NBC screenshots leave out: After 2025, this bill would index the minimum wage to median wages, raising it automatically every year.
INBOX: Democrats, backed by Schumer and Pelosi, set to introduce a bill that would raise the minimum wage to $15 over the course of 5 years.
— Andrew Solender (@AndrewSolender) January 26, 2021
"Thereafter, the federal minimum wage would be indexed to median wage growth." pic.twitter.com/kKxC85BUbf
Here's the full text of the bill.
The minimum wage bill introduced today would phase out the tipped minimum wage loophole, raising it by $2.50 a year until the tipped minimum wage reached parity with the regular minimum wage in 2025.
Similarly, it phases out the separate minimum wage for disabled workers on the same timetable.
It\u2019s brilliant that @ValnevaSE is starting the large-scale manufacture of its potential vaccine, creating 100 high-skilled jobs at their Livingston facility.
— Boris Johnson (@BorisJohnson) January 28, 2021
We\u2019ve secured 60m doses due to be delivered by the end of the year if it is approved for use.https://t.co/4pDUbczlVl
Basically the Government through @katebingham acted like a venture capital fund, funding many vaccine candidates, expensively, across different types of tech, with companies from different countries (at time of some scepticism that a working vaccine could be produced so quickly)
Though despite the fact French Valneva had been funded for its vaccines in general in 2018 by EU’s investment bank, UK funding guaranteed its production in UK (speculative VC style investment) - similarly UK signed deal with Pfizer for German developed/ funded Biontech vaccine
UK approach explicitly focussed on speed (and boosting poor UK vaccine supply chain), at expense of cost. cost of individual batches, and cost of investing in spread of vaccines, not all would eventually be needed/ used...
EU focussed on lower price, & helping smaller EU nations
approach with Astra Zeneca went further - UK Govt via Matt Hancock involved in matchmaking AZ with Oxford University, funded early clinical trials that eg enabled private jets to ferry samples etc - 100m doses and pricing at cost were part of that deal struck at April wave 1 peak
Q3fy21/20 in crs
Rev 1288/730 ,up 76%
Ebidta 433/150
PAT 273/73 ,up 274%
EPS 5.1/1.4
Generic API growth 103% yoy
ARVs up 175% yoy
Generic FDF up 47%
Custom synthesis up 63% yoy
Onco API growth 36%
Generic APIs
ARV,Anti-DM,CVS,PPIs,Onco
Commercialized 60+ products
61 DMFs filed
Generic FDF
ARV,Anti-DM,CVS,PPIs,Onco
Filed 26 ANDAs with USFDA
9 final & 8 tentative approvals
Filed 12 dossiers in Canada, 9 in EU ,8 with WHO,2 in https://t.co/Q35cgK2hvy, 2 in India
Laurus Synthesis
CDMO services for Global pharma
Steroids,hormone mftg
Speciality ingredients in Nutraceuticals,dietary,cosmetics
Commercial scale mfg,clinical phase supplies,Analytics & research
API validation plannd in Unit 5
Optalmic initiated
LSPL-API validatn planned
Revenue breakup in crs
Q3fy21/20
Generic API 731/360
Generic FDF 430/292
Synthesis 127/78
Generic API
ARV 568/214
Onco 64/47
Other 99/99
Generic FDF 430/292
Entered in longterm partnership with leading generic player in EU for contract mfg
Synthesis CDMO 127/78 crs
Synthesis CDMO
Revenue from custom synthesis, strong growth 63% yoy
Total active projects in CDMO stood at 49 in Q3
Partnered Large global pharma & mid ,small biotech companies
Commercial supplies ongoing for 4 products
• 8 powerful ways to use Twitter
• Power of Stocks
• 14 Trading Strategies
• Basics of Derivatives (3 parts)
• Technical Analysis for all sectors
• Tweets of the week
• Books on Futures
All the Top 10 tweets threads I have ever posted to date:
Every week, I post a thread with the top ten tweets.
— Aditya Todmal (@AdityaTodmal) January 7, 2022
People seem to enjoy these a lot.
\U0001f9f5 Here's a list of all of them in order of appearance: \U0001f9f5
Basics of Derivatives Part 1:
\U0001d401\U0001d41a\U0001d42c\U0001d422\U0001d41c\U0001d42c \U0001d428\U0001d41f \U0001d403\U0001d41e\U0001d42b\U0001d422\U0001d42f\U0001d41a\U0001d42d\U0001d422\U0001d42f\U0001d41e\U0001d42c
— Nikita Poojary (@niki_poojary) January 8, 2022
\u2022 What is a derivative
\u2022 Various derivative products
\u2022 Participants in derivatives market
\u2022 Uses of derivative instruments
\u2022 Beta & hedge ratio
\u2022 Option Greeks
Time for a Thread \U0001f9f5
Curated in collaboration with @AdityaTodmal pic.twitter.com/x6IHoQubOT
8 powerful ways to use Twitter:
Most of the Trading community doesn\u2019t know how to use Twitter effectively.
— Aditya Todmal (@AdityaTodmal) January 15, 2022
Here are 8 powerful ways to use Twitter: \U0001f9f5
Collaborated with @niki_poojary pic.twitter.com/TuZt72PIzd
Basics of Derivatives Part 2:
\U0001d401\U0001d41a\U0001d42c\U0001d422\U0001d41c\U0001d42c \U0001d428\U0001d41f \U0001d403\U0001d41e\U0001d42b\U0001d422\U0001d42f\U0001d41a\U0001d42d\U0001d422\U0001d42f\U0001d41e\U0001d42c - \U0001d40f\U0001d41a\U0001d42b\U0001d42d \U0001d408\U0001d408
— Nikita Poojary (@niki_poojary) January 15, 2022
\u2022 How options can be used
\u2022 How to trade in options & exit strategy- buyers
\u2022 Imp of theta decay
\u2022 How to trade in options & exit strategy -sellers
Time for a Thread\U0001f9f5
Curated in collaboration with@AdityaTodmal pic.twitter.com/Ebd99afDKB